Skip to search formSkip to main contentSkip to account menu

W13 (Calmodulin Antagonist)

Known as: W-13, W13 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Transient outward K+ current (Ito) downregulation following sustained tachycardia in vivo is usually attributed to… 
Highly Cited
2007
Highly Cited
2007
Highly Cited
2007
Highly Cited
2007
Membrane-permeable calmodulin inhibitors, such as the napthalenesulfonamide derivatives W-7/W-13, trifluoperazine, and… 
Highly Cited
2006
Highly Cited
2006
  • F. Godlee
  • BMJ : British Medical Journal
  • 2006
  • Corpus ID: 33372969
Comprehensive disclosure could restore public trust 
Highly Cited
1994
Highly Cited
1994
The effect of the calmodulin antagonist N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide (W-13) on the endosomal system of… 
Highly Cited
1993
Highly Cited
1993
Incubation of human chondrocytes with interleukin-1 beta, tumour necrosis factor or endotoxin induced the expression of NO… 
Highly Cited
1992
Highly Cited
1992
Dichlorofluorescein (DCFH) oxidation assay measures hydrogen peroxide (H2O2), which is a derivative of superoxide anion. We found… 
Highly Cited
1992
Highly Cited
1992
Changes in the activity of the brush-border Na-H antiporter are accompanied by parallel changes in the activity of the Na-HCO3… 
Highly Cited
1990
Highly Cited
1990
Permanent cell culture lines derived from human breast cancer tissue are important experimental models in the study of human… 
Highly Cited
1982